Investing.com - Incyte reported on Tuesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Incyte announced earnings per share of $1.01 on revenue of $911.4M. Analysts polled by Investing.com EPS of $0.5573 on revenue of $814.9M.
Incyte 's are down 20.31% and is trading at $77.40 , still down 8.79% from its 52 week high of $84.86 set on Friday, April 8, 2022.
Incyte follows other major Healthcare sector earnings this month
Incyte's report follows an earnings beat by UnitedHealth on Friday, July 15, 2022, who reported EPS of $5.57 on revenue of $80.33B, EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on Tuesday, July 19, 2022 with second quarter EPS of $2.59 on revenue of $24.02B, for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar